AZN AstraZeneca PLC Loading...

From LH earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
13:00
Jul 30 ◎
Adam Schechter CEO, Labcorp Holdings Inc. LH Q2 FY26 call
LabCorp's access expansion enables patients to qualify for AstraZeneca's targeted therapy.
AZN
HIGH

About AZN Analyst Coverage

Buzzberg tracks AZN (AstraZeneca PLC) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 1 total trade idea tracked. Latest voices: Adam Schechter.